Larvol Delta - Neoadjuvant-CADI05-in-Combination-With-Pembrolizumab-for-Surgically-Resectable-Locally-Advanced-Head-and-Neck-Squamous-Cell-Carcinomas

Keytruda (pembrolizumab) - Merck (MSD)

Mycidac-C (mycobacterium indicus pranii heat-killed) - Cadila

http://clinicaltrials.gov/ct2/show/NCT07455032

Mar 7, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next